Isomorphic Labs is a London-based drug developer that’s owned and operated by Alphabet Inc. The company was founded in 2021 as an offshoot from DeepMind , Google’s multidisciplinary AI ...

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are also racing to use AI in drug discovery.

A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But can we trust drugs designed by a mind that isn't human?

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

For the first of these tasks Dr Baker and his colleagues use RF diffusion, an AI model they have developed to predict a ...

Precision oncology leader joins world-class team as company enters next phase of translating AI-driven drug discovery into life-changing medicines. As Chief Medical Officer, Dr. Wolf will bring ...

Alphabet’s AI-powered drug discovery company, Isomorphic Labs, is preparing to take its first major leap into the real world. After years of development, the company says it’s now gearing up for human ...

Isomorphic Labs, a drug discovery company spun out of Google DeepMind, is about to make a historic breakthrough ... DeepMind’s revolutionary AlphaFold AI system gave birth to Isomorphic Labs, which ...

Researchers are urging developers to prioritize research into “chain-of-thought” processes, which provide a window into how ...